Biotech Values

[DewDiligence]

Follow-up survey re MNTA-Amphastar pre-launch maneuvers…

Q: Assuming that MNTA sues Amphastar for patent infringement (which is
now certain based on today’s webcast), what is the most likely outcome?

a) A negotiated settlement in which Amphastar licenses MNTA’s Lovenox patents and pays MNTA a small royalty on sales of Amphastar’s product.

b) A negotiated settlement in which Amphastar delays its launch in some manner.

c) A temporary restraining order preventing Amphastar’s launch until the Court evaluates the legal arguments.

d) Amphastar ignores the lawsuit and proceeds with its product launch.


To vote, please go to
http://www.investorshub.com/boards/board_surveymenu.asp?board_id=1418
and select survey #143.

Note: You may vote in any listed survey in which you have not already voted.